Researchers Isolate Antimycobacterial Compound From Plant

A study identifies six compounds in Zanthoxylum flavum subsp. pistaciifolium leaves with potential medical properties.

Updated on Oct. 22, 2026 in Botany

A green leaf rests beside a glass vial on a white laboratory surface, representing botanical medical research.
Researchers have identified six bioactive compounds in Zanthoxylum flavum subsp. pistaciifolium leaves, highlighting potential new pathways for treating tuberculosis and respiratory infections. AI Illustration. Upload story photo >

Scientists have isolated six distinct compounds from the leaves of the Zanthoxylum flavum subsp. pistaciifolium plant, a species native to Cuba. One specific compound, gamma-fagarine, demonstrated significant antimycobacterial activity and selective cytotoxicity against cancer cell lines.

Why it matters

The findings provide a scientific basis for the traditional use of the plant in treating respiratory infections. Identifying bioactive compounds offers potential avenues for developing new therapeutic agents for tuberculosis and related conditions.

Researchers utilized LC-MS, 1D/2D NMR, and ECD spectra to characterize the compounds. The study tested gamma-fagarine at 10 µM, demonstrating selective cytotoxicity against A549, A2780, and MCF-7 cell lines while showing no toxicity toward MRC-5 fibroblasts.

The players

Zanthoxylum flavum subsp. pistaciifolium

This plant species, native to Cuba, is traditionally utilized in folk medicine for the treatment of various respiratory infections.

The details

The research team employed a checkerboard assay to test the synergy between gamma-fagarine and rifampicin. Molecular docking predictions were also developed, offering a structural hypothesis for how these compounds interact with target biological pathways.

Timeline

  1. October 22, 2026: The research findings were published.

The Big Picture

This discovery contributes to the ongoing search for novel anti-tuberculosis agents by identifying specific botanical compounds that inhibit bacterial growth. It shifts the paradigm from traditional folk usage toward validated molecular pharmacology for respiratory disease.

The identification of these specific compounds could eventually lead to the development of new, more effective pharmaceutical treatments for mycobacterial infections. By confirming which molecules are responsible for the plant's medicinal properties, researchers can better design synthetic drugs that target harmful bacteria while minimizing cellular toxicity.

The takeaway

This study highlights the value of investigating traditional medicinal plants for modern medical breakthroughs. Readers should note that traditional remedies often contain complex mixtures, and identifying single active ingredients is key to ensuring safety and potency.

Further reading

Explore more findings in the field of Botany.